GlycoBrick

These oligosaccharides are produced in an activated form containing a terminal reactive azide or alkynyl group that make possible their use as standard building blocks in click chemistry reactions. They can be used as starting material for the design of macromolecular structures such as glycopolymers, glyconanoparticules, and affinity purification columns. These oligosaccharides are produced at the gram scale by bacterial fermentation, extracted purified by standardized processes. The products are consistent with internal standards.  Fermentation process can be scaled up for oligosaccharide production on a multi kg scale. 

GLY200
core type 1
Gal
β-3GlcNAcβ-3Gal-R 
5 mg, 25 mg, 1 g, 5 g 

GLY201a
core type
2Gal
β-4GlcNAcβ-3Gal-R  
5 mg, 25 mg, 1 g, 5 g 

GLY201b
core type
4Gal
β-3GalNAcβ-3Gal-R
5 mg, 25 mg, 1 g, 5 g 

GLY202

Sialyl type 1

Neu5Ac
α-3Galβ-3GlcNAcβ-3Gal-R
5 mg, 25 mg, 1 g, 5 g 

GLY203

Sialyl type 2

Neu5Ac
α-3Galβ-4GlcNAcβ-3Gal-R
5 mg, 25 mg, 1 g, 5 g 

GLY204

H type 1

Fuc
α-2Galβ-3GlcNAcβ-3Gal-R
5 mg, 25 mg, 1 g, 5 g 

GLY204

H type 1

Fucα
-2Galβ-3GlcNAcβ-3Gal-R
5 mg, 25 mg, 1 g, 5 g 

GLY205
H type 2
Fuc
α-2Galβ-4GlcNAcβ-3Gal-R
5 mg, 25 mg, 1 g, 5 g 

GLY206
H type 4
Fuc
α-2Galβ-3GalNAcβ-3Gal-R
5 mg, 25 mg, 1 g, 5 g 

GLY207
A type 1
GalNAcα
-3(Fucα-2)Galβ-3GlcNAcβ-3Gal-R
5 mg, 25 mg, 1 g, 5 g 

GLY208
A type 2
GalNAc
α-3(Fucα-2)Galβ-4GlcNAcβ-3Gal-R
5 mg, 25 mg, 1 g, 5 g 

GLY209
A type 4
GalNAc
α-3(Fucα-2)Galβ-3GalNAcβ-3Gal-R
5 mg, 25 mg, 1 g, 5 g 

GLY210
B type 1
Gal
α-3(Fucα-2)Galβ-3GlcNAcβ-3Gal-R
5 mg, 25 mg, 1 g, 5 g 

GLY211
B type 2
Gal
α-3(Fucα-2)Galβ-4GlcNAcβ-3Gal-R
5 mg, 25 mg, 1 g, 5 g 

 

GLY212
B type 4
Gal
α-3(Fucα-2)Galβ-3GalNAcβ-3Gal-R
5 mg, 25 mg, 1 g, 5 g 

GLY213
xeno
Gal
α-3Galβ-4GlcNAcβ-3Gal-R
5 mg, 25 mg, 1 g, 5 g 

GLY214
Lewis X
Gal
β-4(Fucα-3)GlcNAcβ-3Gal-R 
5 mg, 25 mg, 1 g, 5 g 

GLY215
Sialyl lewis X
Neu5Ac
α-3Galβ-4(Fucα-3)GlcNAcβ-3Gal-R
5 mg, 25 mg, 1 g, 5 g 

GLY216
LewisY
Fuc
α-2Galβ-4(Fucα-3)GlcNAcβ-3Gal-R
5 mg, 25 mg, 1 g, 5 g 

GLY217
Sialyl lewis Y
Neu5Ac
α-3Galβ-3(Fucα-4)GlcNAcβ-3Gal-R
5 mg, 25 mg, 1 g, 5 g 

GLY218
Lewis A
Gal
β-3(Fucα-4)GlcNAcβ-3Gal-R
5 mg, 25 mg, 1 g, 5 g 

GLY219
Lewis B
Fuc
α-2Galβ-3(Fucα-4)GlcNAcβ-3Gal-R
5 mg, 25 mg, 1 g, 5 g 

 

ELICITYL - OligoTech® - GlycoBrick
Research and production of highly purified oligosaccharides
for agriculture, pharmacy, nutraceutics and cosmetics.
Download OligoTech®
complex sugar catalogue
   

Terms & conditions - Site map - Legal

Design Hugo FUSTIER - Référencement Grenoble Focoweb

Elicityl SA
746, avenue Ambroise Croizat - F-38920 Crolles - France
tel: +33 (0)4 76 40 71 61 - fax: +33 (0)4 76 45 59 50
e-mail: contact@elicityl.fr